Prostaglandin E 2 induces fibroblast apoptosis by modulating multiple survival pathways
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Although the lipid mediator prostaglandin E(2) (PGE(2)) exerts antifibrotic effects by inhibiting multiple fibroblast functions, its ability to regulate fibroblast survival is unknown. Here, we examined the effects of this prostanoid on apoptosis and apoptosis pathways in normal and fibrotic lung fibroblasts. As compared to medium alone, 24 h of treatment with PGE(2) increased apoptosis of normal lung fibroblasts in a dose-dependent manner (EC(50) approximately 50 nM), as measured by annexin V staining, caspase 3 activity, cleavage of poly-ADP-ribose polymerase, and single-stranded DNA levels. PGE(2) also potentiated apoptosis elicited by Fas ligand plus cycloheximide. These proapoptotic actions were dependent on signaling through the EP2/EP4 receptors and by downstream activation of both caspases 8 and 9. Silencing and gene deletion of PTEN demonstrated that the effects of PGE(2) involved decreased activity of the prosurvival molecule Akt. PGE(2) also down-regulated expression of survivin, an inhibitor of apoptosis, and increased expression of Fas. Fibroblasts from patients with pulmonary fibrosis exhibited resistance to the apoptotic effects of PGE(2). These findings show for the first time that, in contrast to its effects on many other cell types, PGE(2) promotes apoptosis in lung fibroblasts through diverse pathways. They provide another dimension by which PGE(2) may inhibit, and perhaps even reverse, fibrogenesis in patients with interstitial lung disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prostaglandin E2 has similar effects on formation and apoptosis in lung and keloid fibroblasts (145–147).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [145]
Citations
Cites
Thornberry, N. A., & Lazebnik, Y. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,887
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594 · cited 1×
“PIP3 is a lipid mediator that recruits and activates proteins with pleckstrin homology domains such as Akt, which has been shown to be an important prosurvival mediator (41) that can inhibit both the intrinsic (42) and extrinsic (43) apoptotic pathways.”
BackgroundDanial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104 · cited 3×
“PTEN is a lipid phosphatase that antagonizes the phosphatidylinositol-3-kinase (PI3K) pathway by dephosphorylating phosphatidylinositol 3,4,5-trisphosphate (PIP3) (40).”
BackgroundMitochondrial control of cell death
Kroemer, G., & Reed, J. C. (2000) · Nature Medicine · doi:10.1038/74994 · Cited by 3,103 · cited 1×
“with activation of the apoptosome complex containing caspase 9, which leads to further cleavage of downstream effector caspases 3, 6, and 7 (35).”
BackgroundRegulation of Cell Death Protease Caspase-9 by Phosphorylation
Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., Franke, T. F., Stanbridge, E., Frisch, S., & Reed, J. C. (1998) · Science · doi:10.1126/science.282.5392.1318 · Cited by 2,481 · cited 1×
“PIP3 is a lipid mediator that recruits and activates proteins with pleckstrin homology domains such as Akt, which has been shown to be an important prosurvival mediator (41) that can inhibit both the intrinsic (42) and extrinsic (43) apoptotic pathways.”
BackgroundSelman, M., King, T. E., & Pardo, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00015 · Cited by 1,786
Desmoulière, A., Redard, M., Darby, I. A., & Gabbiani, G. (1995) · Europe PMC (PubMed Central) · Cited by 1,448
Overview of cell death signaling pathways
Jin, Z., & El-Deiry, W. S. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.2.1508 · Cited by 1,326 · cited 1×
“, Fas), which, in turn, triggers the formation of the death-induced signaling complex, which leads to activation of caspase 8 (36, 37); activated caspase 8 further cleaves downstream effector caspases.”
BackgroundModulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.
Sheng, H., Shao, J., Morrow, J. D., Beauchamp, R. D., & Dubois, R. N. (1998) · PubMed · Cited by 1,114
The inhibitors of apoptosis (IAPs) and their emerging role in cancer
LaCasse, E. C., Baird, S., Korneluk, R. G., & MacKenzie, A. E. (1998) · Oncogene · doi:10.1038/sj.onc.1202569 · Cited by 982
Prostaglandin E 2 Promotes Colon Cancer Cell Growth Through a G s -Axin-ß-Catenin Signaling Axis
Castellone, M. D., Teramoto, H., Williams, B. O., Druey, K. M., & Gutkind, J. S. (2005) · Science · doi:10.1126/science.1116221 · Cited by 883
Apo2L/TRAIL and its death and decoy receptors
LeBlanc, H. N., & Ashkenazi, A. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401187 · Cited by 854 · cited 1×
“, Fas), which, in turn, triggers the formation of the death-induced signaling complex, which leads to activation of caspase 8 (36, 37); activated caspase 8 further cleaves downstream effector caspases.”
BackgroundInhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer.
Kawasaki, H., Altieri, D. C., Lu, C., Toyoda, M., Tenjo, T., & Tanigawa, N. (1998) · PubMed · Cited by 706
Wilborn, J., Crofford, L. J., Burdick, M. D., Kunkel, S. L., Strieter, R. M., & Peters-Golden, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117866 · Cited by 392 · cited 3×
“Multiple mechanisms (diminished EP2 expression, diminished protein kinase A expression, and activity) accounted for resistance to PGE2 inhibition of collagen synthesis and cell proliferation (14).”
BackgroundResultSelf-citationTGF‐β signaling: A tale of two responses
Rahimi, R. A., & Leof, E. B. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21501 · Cited by 371 · cited 1×
“The importance of TGF- as a profibrotic mediator derives in part from its ability to promote each of these opposing effects—a phenomenon that has been termed the “apoptosis paradox” (7, 51).”
BackgroundEvolving Concepts of Apoptosis in Idiopathic Pulmonary Fibrosis
Thannickal, V. J., & Horowitz, J. C. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200601-001tk · Cited by 364 · cited 1×
“The importance of TGF- as a profibrotic mediator derives in part from its ability to promote each of these opposing effects—a phenomenon that has been termed the “apoptosis paradox” (7, 51).”
BackgroundSelf-citationCurtis, M. J., & Wolpert, T. J. (2004) · The Plant Journal · doi:10.1111/j.1365-313x.2004.02040.x · Cited by 333
YIN, X.-M. (2000) · Cell Research · doi:10.1038/sj.cr.7290045 · Cited by 313
Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung
Uhal, B. D., Joshi, I., Hughes, W. F., Ramos, C., Pardo, A., & Selman, M. (1998) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1998.275.6.l1192 · Cited by 296
Kolodsick, J. E., Peters-Golden, M., Larios, J., Toews, G. B., Thannickal, V. J., & Moore, B. B. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0243oc · Cited by 294
Self-citationKeerthisingam, C. B., Jenkins, R. G., Harrison, N. K., Hernandez-Rodriguez, N. A., Booth, H., Laurent, G. J., Hart, S. L., Foster, M. L., & McAnulty, R. J. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64092-8 · Cited by 241
Horowitz, J. C., Lee, D. Y., Waghray, M., Keshamouni, V. G., Thomas, P. E., Zhang, H., Cui, Z., & Thannickal, V. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306248200 · Cited by 239 · cited 2×
“We measured ssDNA by immunoassay, as described previously (32).”
MethodSelf-citationPlataki, M., Koutsopoulos, A. V., Darivianaki, K., Delides, G., Siafakas, N. M., & Bouros, D. (2005) · Chest · doi:10.1378/chest.127.1.266 · Cited by 237
Bitterman, P. B., Wewers, M. D., Rennard, S. I., Adelberg, S., & Crystal, R. G. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112364 · Cited by 232 · cited 1×
“and macrophages (18, 19), PGE2 inhibits fibroblast proliferation (18, 19), collagen synthesis (20), migra-”
BackgroundBarbas-Filho, J. V., Ferreira, M. A., Sesso, A., Kairalla, R. A., Carvalho, C. R. R., & Capelozzi, V. L. (2001) · Journal of Clinical Pathology · doi:10.1136/jcp.54.2.132 · Cited by 229
PKB and the mitochondria: AKTing on apoptosis
Parcellier, A., Tintignac, L. A., Zhuravleva, E., & Hemmings, B. A. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2007.07.010 · Cited by 220 · cited 3×
“deletion indicate that PGE2-induced fibroblast apoptosis is dependent on PTEN activation; this results in down-regulation of Akt, a molecule that has been shown to be important in prosurvival signaling (41).”
BackgroundWhite, E. S., Atrasz, R. G., Hu, B., Phan, S. H., Stambolic, V., Mak, T. W., Hogaboam, C. M., Flaherty, K. R., Martinez, F. J., Kontos, C. D., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200507-1058oc · Cited by 204
Self-citationHuang, S., Wettlaufer, S. H., Hogaboam, C., Aronoff, D. M., & Peters-Golden, M. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00232.2006 · Cited by 175 · cited 2×
“Proteins from cell lysates were separated by SDS-PAGE and transferred to nitrocellulose membranes for immunoblotting, as described previously (33).”
BackgroundMethodSelf-citationProstaglandin E2inhibits fibroblast chemotaxis
Kohyama, T., Ertl, R. F., Valenti, V., Spurzem, J., Kawamoto, M., Nakamura, Y., Veys, T., Allegra, L., Romberger, D., & Rennard, S. I. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.5.l1257 · Cited by 168 · cited 1×
“tion (21, 22), and differentiation into myofibroblasts”
Tessner, T. G., Muhale, F., Riehl, T. E., Anant, S., & Stenson, W. F. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422218 · Cited by 167 · cited 4×
“epithelial cells may be explained by differences in PTEN/ Akt signaling, since we have shown that PGE2 activates PTEN and inhibits Akt (21) in the former, while it activates Akt in epithelial (24) and cancer cells (52).”
BackgroundInfluentialGM-CSF Regulates Bleomycin-Induced Pulmonary Fibrosis Via a Prostaglandin-Dependent Mechanism
Moore, B. B., Coffey, M. J., Christensen, P., Sitterding, S., Ngan, R., Wilke, C. A., McDonald, R., Phare, S. M., Peters-Golden, M., Paine, R., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.4032 · Cited by 158 · cited 1×
“However, it is of interest that the cyclooxygenase inhibitor indomethacin was shown to worsen bleomycin-induced fibrosis in mice (56).”
BackgroundSelf-citationSurvivin gene expression in early‐stage non‐small cell lung cancer
Falleni, M., Pellegrini, C., Marchetti, A., Oprandi, B., Buttitta, F., Barassi, F., Santambrogio, L., Coggi, G., & Bòsari, S. (2003) · The Journal of Pathology · doi:10.1002/path.1388 · Cited by 150
Nishihara, H., Kizaka‐Kondoh, S., Insel, P. A., & Eckmann, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533221100 · Cited by 147 · cited 3×
“That PGE2 acts as an antiapoptotic signal in epithelial cells (24, 25) but as a proapoptotic signal in fibroblasts therefore signifies another such apoptosis paradox and emphasizes the pleiotropic antifibrotic potential of PGE2.”
BackgroundBleomycin-Induced E Prostanoid Receptor Changes Alter Fibroblast Responses to Prostaglandin E2
Moore, B. B., Ballinger, M. N., White, E. S., Green, M. E., Herrygers, A. B., Wilke, C. A., Toews, G. B., & Peters-Golden, M. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5644 · Cited by 135 · cited 1×
“relative deficiency of PGE2 production (12–14) and responsiveness (15, 16), and the latter has also been”
BackgroundSelf-citationCOX‐2‐dependent stabilization of survivin in non‐small cell lung cancer
Krysan, K., Merchant, F. H., Zhu, L., Dohadwala, M., Luo, J., Lin, Y., Heuzé‐Vourc'h, N., Pǒld, M., Seligson, D. B., Chia, D., et al. (2003) · The FASEB Journal · doi:10.1096/fj.03-0369fje · Cited by 133 · cited 2×
“7A), which is in contrast to the action of this prostanoid observed in cancer cells (48, 49).”
BackgroundResultWhite, E. S., Atrasz, R. G., Dickie, E. G., Aronoff, D. M., Stambolic, V., Mak, T. W., Moore, B. B., & Peters-Golden, M. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0126oc · Cited by 131 · cited 5×
“In lung fibroblasts, the G scoupled EP2 is the most abundantly expressed (33) and mediates the signaling necessary for inhibition of collagen synthesis, cell proliferation (33), and fibroblast migration (21).”
BackgroundInfluentialSelf-citationDong, Q., Louahed, J., Vink, A., Sullivan, C. D., Messler, C. J., Zhou, Y., Haczku, A., Huaux, F., Arras, M., Holroyd, K. J., et al. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199907)29:07<2130::aid-immu2130>3.0.co;2-s · Cited by 128
Hodges, R. J., Jenkins, R. G., Wheeler-Jones, C. P. D., Copeman, D. M., Bottoms, S. E., Bellingan, G. J., Nanthakumar, C. B., Laurent, G. J., Hart, S. L., Foster, M. L., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63423-2 · Cited by 125
Fine, A., Poliks, C. F., Donahue, L. P., Smith, B. D., & Goldstein, R. H. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71448-8 · Cited by 110 · cited 1×
“and macrophages (18, 19), PGE2 inhibits fibroblast proliferation (18, 19), collagen synthesis (20), migra-”
BackgroundJeong, J. C., Kim, M. S., Kim, T. H., & Kim, Y. K. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9868-5 · Cited by 107 · cited 1×
“signaling (47) and has been shown to be up-regulated”
BackgroundHuman alveolar macrophage inhibition of lung fibroblast growth. A prostaglandin-dependent process.
Elias, J. A., Rossman, M. D., Zurier, R. B., & Daniele, R. P. (1985) · PubMed · doi:10.1164/arrd.1985.131.1.94 · Cited by 107 · cited 1×
“and macrophages (18, 19), PGE2 inhibits fibroblast proliferation (18, 19), collagen synthesis (20), migra-”
BackgroundSweeney, E. A., Inokuchi, J.-I., & Igarashi, Y. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00198-7 · Cited by 99 · cited 1×
“4A, B), at concentrations used in other studies (38, 39), independently inhibited PGE2induced apoptosis.”
BackgroundMoodley, Y. P., Caterina, P., Scaffidi, A. K., Misso, N. L., Papadimitriou, J. M., McAnulty, R. J., Laurent, G. J., Thompson, P. J., & Knight, D. A. (2004) · The Journal of Pathology · doi:10.1002/path.1531 · Cited by 99 · cited 3×
“Previous studies have also shown that UIP fibroblasts are resistant to FasL-induced apoptosis (10, 11), and data in Fig.”
BackgroundResultHawcroft, G., Ko, C. W. S., & Hull, M. A. (2006) · Oncogene · doi:10.1038/sj.onc.1210113 · Cited by 93 · cited 2×
“PGE2 has been shown to be antiapoptotic in multiple cell types, including normal epithelial cells (24, 25), cancer cells (26, 27), T cells (28, 29), and adipocytes (30).”
BackgroundRosner, D., Stoneman, V. E. A., Littlewood, T. D., McCarthy, N. J., Figg, N. L., Wang, Y., Tellides, G., & Bennett, M. R. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050473 · Cited by 93
Variable Prostaglandin E2 Resistance in Fibroblasts from Patients with Usual Interstitial Pneumonia
Huang, S. K., Wettlaufer, S. H., Hogaboam, C. M., Flaherty, K. R., Martínez, F. J., Myers, J. L., Colby, T. V., Travis, W. D., Toews, G. B., & Peters-Golden, M. L. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200706-963oc · Cited by 83 · cited 3×
“This variable response among different UIP fibroblast lines is consistent with the variable inhibitory effects of PGE2 on collagen expression and cell proliferation, which we observed previously (16).”
BackgroundSelf-citationBühling, F., Wille, A., Röcken, C., Wiesner, O., Baier, A., Meinecke, I., Welte, T., & Pap, T. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-37 · Cited by 75
Study of caspase inhibitors for limiting death in mammalian cell culture
Sauerwald, T. M., Oyler, G. A., & Betenbaugh, M. J. (2003) · Biotechnology and Bioengineering · doi:10.1002/bit.10473 · Cited by 74 · cited 1×
“4A, B), at concentrations used in other studies (38, 39), independently inhibited PGE2induced apoptosis.”
BackgroundLin, J., Hsiao, P.-W., Chiu, T. H., & Chao, J. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.05.028 · Cited by 72 · cited 2×
“7A), which is in contrast to the action of this prostanoid observed in cancer cells (48, 49).”
BackgroundResultArachidonic acid metabolism by rat alveolar epithelial cells.
Chauncey, J. B., Peters-Golden, M. L., & Simon, R. (1988) · PubMed · Cited by 68
Self-citationPorter, B. O., & Malek, T. R. (1999) · European Journal of Immunology · Cited by 60
Horowitz, J. C., Cui, Z., Moore, T. A., Meier, T. R., Reddy, R. C., Toews, G. B., Standiford, T. J., & Thannickal, V. J. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00276.2005 · Cited by 58
Self-citationEscape from the Matrix: Multiple Mechanisms for Fibroblast Activation in Pulmonary Fibrosis
Laurent, G. J., McAnulty, R. J., Hill, M., & Chambers, R. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200710-159dr · Cited by 54
Weinlich, R., Bortoluci, K. R., Chehab, C. F., Serezani, C. H., Ulbrich, A. G., Peters-Golden, M. L., Russo, M., & Amarante-Mendes, G. P. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.128 · Cited by 48 · cited 1×
“PGE2 has been shown to be antiapoptotic in multiple cell types, including normal epithelial cells (24, 25), cancer cells (26, 27), T cells (28, 29), and adipocytes (30).”
BackgroundSelf-citationSugiura, H., Liu, X., Togo, S., Kobayashi, T., Shen, L., Kawasaki, S., Kamio, K., Wang, X., Mao, L. J., & Rennard, S. I. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20825 · Cited by 26
Arachidonate metabolism increases as rat alveolar type II cells differentiate in vitro
Lipchik, R. J., Chauncey, J. B., Paine, R., Simon, R. H., & Peters-Golden, M. L. (1990) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1990.259.2.l73 · Cited by 21 · cited 1×
“As PGE2 is the major cyclooxygenase-derived prostanoid produced by both alveolar epithelial cells (57) and fibroblasts (57), it has the capability to elicit fibroblast apoptosis in both a paracrine and autocrine fashion.”
BackgroundSelf-citationApproaches to Evaluation of Fibrogenic Pathways in Surgical Lung Biopsy Specimens
Hogaboam, C. M., Carpenter, K. J., Evanoff, H. L., & Kunkel, S. L. (2005) · Humana Press eBooks · doi:10.1385/1-59259-940-0:209 · Cited by 17 · cited 1×
“All patient-derived cells were isolated as described previously (31).”
BackgroundSelf-citationHuman Alveolar Macrophage Inhibition of Lung Fibroblast Growth
Elias, J. A., Rossman, M. D., Zurier, R. B., & Daniele, R. P. (2015) · American Review of Respiratory Disease · Cited by 13
Nishimura, K., Setoyama, T., TSUMAGARI, H., MIYATA, N., Hatano, Y., Li, X., Jisaka, M., Nagaya, T., & Yokota, K. (2006) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.60106 · Cited by 13
Research works printed but not linked: 2
- 10.1172/jci22218 · doi:10.1172/jci22218 · Paper page
- 10.1002/(sici)1521-4141(199907)29:07<2360::aid-immu2360>3.0.co;2-a · doi:10.1002/(sici)1521-4141(199907)29:07<2360::aid-immu2360>3.0.co;2-a
Cited by
Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases
Hinz, B., & Lagares, D. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0324-5 · Cited by 614
Diverse functions of matrix metalloproteinases during fibrosis
Giannandrea, M., & Parks, W. C. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.012062 · Cited by 541
“PGE2 suppresses fibrosis by inhibiting fibroblast migration, proliferation, collagen synthesis and differentiation into myofibroblasts (Huang et al., 2009; Kolodsick et al., 2003; White et al., 2005).”
BackgroundMatrix Metalloproteinases as Therapeutic Targets for Idiopathic Pulmonary Fibrosis
Craig, V. J., Zhang, L., Hagood, J. S., & Owen, C. A. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0020tr · Cited by 507
Myofibroblast differentiation and survival in fibrotic disease
Kis, K., Liu, X., & Hagood, J. S. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001967 · Cited by 224
Diminished Prostaglandin E 2 Contributes to the Apoptosis Paradox in Idiopathic Pulmonary Fibrosis
Maher, T. M., Evans, I. C., Bottoms, S. E., Mercer, P. F., Thorley, A. J., Nicholson, A. G., Laurent, G. J., Tetley, T. D., Chambers, R. C., & McAnulty, R. J. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200905-0674oc · Cited by 196
Metadata
- Authors
- Huang, S. K., White, E. S., Wettlaufer, S. H., Grifka, H., Hogaboam, C. M., Thannickal, V. J., Horowitz, J. C., & Peters-Golden, M.
- Affiliations
- University of Michigan (US)
- Division of Pulmonary and Critical Care Medicine Department of Internal Medicine University of Michigan Medical School Ann Arbor Michigan USA
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2009-08-11
- Volume
- 23
- Issue
- 12
- Pages
- 4317-4326
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC2812040
- OpenAlex
- W2133907923
- Cited by
- 147
- References
- 59
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 3 · 2023: 6 · 2022: 8 · 2021: 12 · 2020: 7 · 2019: 7 · 2018: 13 · 2017: 5 · 2016: 8 · 2015: 15 · 2014: 12 · 2013: 10 · 2012: 11
- FWCI
- 7.45
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Deep Blue (University of Michigan) (submittedVersion)
- Funders
- National Institutes of Health (P50 HL56402)
- National Heart, Lung, and Blood Institute
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- prostaglandin E2, fibroblast apoptosis, lung fibroblasts, pulmonary fibrosis, EP2 receptor, EP4 receptor, caspase-8, caspase-9, PTEN, Akt signaling, survivin, Fas ligand, interstitial lung disease, fibrogenesis
- MeSH terms
- Cell Line, Fibroblasts, Gene Expression Regulation, Humans, Lung, Dinoprostone, Signal Transduction, Apoptosis, PTEN Phosphohydrolase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.